These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 16343437)

  • 21. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
    Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
    Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.
    Shang D; Liu Y; Xu X; Han T; Tian Y
    Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unsaturated Fatty Acids Stimulate Tumor Growth through Stabilization of β-Catenin.
    Kim H; Rodriguez-Navas C; Kollipara RK; Kapur P; Pedrosa I; Brugarolas J; Kittler R; Ye J
    Cell Rep; 2015 Oct; 13(3):495-503. PubMed ID: 26456834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of changes of expression of the Wnt/β-catenin signaling pathway in renal clear cell carcinoma.
    Liu Z; Liu XW; Liu SA; Lv JJ; Fu Q
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(23):4840-4845. PubMed ID: 27981554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin.
    Lilien J; Balsamo J
    Curr Opin Cell Biol; 2005 Oct; 17(5):459-65. PubMed ID: 16099633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of reptin in renal cell carcinoma contributes to tumor malignancies and its inhibition triggers senescence of cancer cells.
    Ren J; Li W; Liu H; Yan L; Jiao W; Li D; Tang Y; Gu G; Xu Z
    Urol Oncol; 2013 Oct; 31(7):1358-66. PubMed ID: 22341977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.
    Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Darwish OM; Haddad AQ; Khalil D; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
    J Urol; 2014 Jun; 191(6):1671-7. PubMed ID: 24291548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CIP4 controls CCL19-driven cell steering and chemotaxis in chronic lymphocytic leukemia.
    Malet-Engra G; Viaud J; Ysebaert L; Farcé M; Lafouresse F; Laurent G; Gaits-Iacovoni F; Scita G; Dupré L
    Cancer Res; 2013 Jun; 73(11):3412-24. PubMed ID: 23644527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The TC10-interacting protein CIP4/2 is required for insulin-stimulated Glut4 translocation in 3T3L1 adipocytes.
    Chang L; Adams RD; Saltiel AR
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):12835-40. PubMed ID: 12242347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma.
    Sun S; Ning X; Liu J; Liu L; Chen Y; Han S; Zhang Y; Liang J; Wu K; Fan D
    Biochem Biophys Res Commun; 2007 May; 356(4):864-71. PubMed ID: 17400182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.
    Cooper SJ; Zou H; Legrand SN; Marlow LA; von Roemeling CA; Radisky DC; Wu KJ; Hempel N; Margulis V; Tun HW; Blobe GC; Wood CG; Copland JA
    Oncogene; 2010 May; 29(20):2905-15. PubMed ID: 20208565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.
    Pan J; Mestas J; Burdick MD; Phillips RJ; Thomas GV; Reckamp K; Belperio JA; Strieter RM
    Mol Cancer; 2006 Nov; 5():56. PubMed ID: 17083723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
    Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
    J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migration of renal carcinoma cells is dependent on protein kinase Cdelta via beta1 integrin and focal adhesion kinase.
    Brenner W; Greber I; Gudejko-Thiel J; Beitz S; Schneider E; Walenta S; Peters K; Unger R; Thüroff JW
    Int J Oncol; 2008 May; 32(5):1125-31. PubMed ID: 18425341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disruption of cell adhesion in renal epithelium without cadherin loss.
    O'Donnell M; Fleming S
    J Pathol; 1995 Jan; 175(1):45-50. PubMed ID: 7891226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Cdc42-interacting protein-4 (CIP4) gene knock-out mouse reveals delayed and decreased endocytosis.
    Feng Y; Hartig SM; Bechill JE; Blanchard EG; Caudell E; Corey SJ
    J Biol Chem; 2010 Feb; 285(7):4348-54. PubMed ID: 19920150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and gene expression analysis of novel matched primary and metastatic renal cell carcinoma cell lines.
    Ohno Y; Izumi M; Tachibana M; Kawamura T; Yoshioka K; Aoyagi T; Ohori M; Namiki K; Sakamoto N; Nakagami Y; Hatano T; Akimoto S; Nishimura T
    Oncol Rep; 2008 Sep; 20(3):501-9. PubMed ID: 18695898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cytoskeletal organizing protein Cdc42-interacting protein 4 associates with phosphorylase kinase in skeletal muscle.
    Archila S; King MA; Carlson GM; Rice NA
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1592-9. PubMed ID: 16735024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.